BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37964329)

  • 1. Artificial neural network-based gene screening and immune cell infiltration analysis of osteosarcoma feature.
    Shi S; Guo Y; Wang Q; Huang Y
    J Gene Med; 2024 Jan; 26(1):e3622. PubMed ID: 37964329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CENPE, PRC1, TTK, and PLK4 May Play Crucial Roles in the Osteosarcoma Progression.
    Wang F; Zhao Q; Liu W; Kong D
    Technol Cancer Res Treat; 2020; 19():1533033820973278. PubMed ID: 33176597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
    Tan S; Chao R
    Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration.
    Li J; Shi H; Yuan Z; Wu Z; Li H; Liu Y; Lu M; Lu M
    BMC Cancer; 2022 Jan; 22(1):108. PubMed ID: 35078433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Genes and Pathways in Osteosarcoma by Bioinformatics Analysis.
    Chen X; Zhang N; Zheng Y; Tong Z; Yang T; Kang X; He Y; Dong L
    Comput Math Methods Med; 2022; 2022():7549894. PubMed ID: 35075370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
    Zheng H; Wang Y; Li F
    Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of differentially expressed genes in osteosarcoma based on gene expression data.
    Yang Z; Chen Y; Fu Y; Yang Y; Zhang Y; Chen Y; Li D
    BMC Med Genet; 2014 Jul; 15():80. PubMed ID: 25023069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioinformatics Analysis on Key Genes and Immune Infiltration of Osteosarcoma].
    Li S; Zheng ZZ; Zhang YP; Liu ZQ; Xiao SP; Ouyang ZX; Wang B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):110-117. PubMed ID: 35300772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
    Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
    Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
    Tian W; Li Y; Zhang J; Li J; Gao J
    Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis.
    Liu D; Zhou R; Zhou A
    Medicine (Baltimore); 2021 Feb; 100(6):e24471. PubMed ID: 33578541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the key genes and pathways of side population cells in human osteosarcoma using gene expression array analysis.
    Ren YM; Duan YH; Sun YB; Yang T; Zhao WJ; Zhang DL; Tian ZW; Tian MQ
    J Orthop Surg Res; 2018 Jun; 13(1):153. PubMed ID: 29921292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.